<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-TKNMKSIX</identifier><date>2015</date><creator>Ocvirk, Janja</creator><relation>documents/doc/T/URN_NBN_SI_doc-TKNMKSIX_001.pdf</relation><relation>documents/doc/T/URN_NBN_SI_doc-TKNMKSIX_001.txt</relation><format format_type="issue">1</format><format format_type="volume">19</format><format format_type="type">article</format><format format_type="extent">str. 13-16, 37</format><identifier identifier_type="ISSN">1408-1741</identifier><identifier identifier_type="COBISSID">2139003</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-TKNMKSIX</identifier><language>slv</language><publisher>Onkološki inštitut Ljubljana</publisher><source>Onkologija (Ljubljana)</source><rights>BY</rights><subject language_type_id="slv">bazalnocelični karcinom</subject><subject language_type_id="slv">kožni rak</subject><subject language_type_id="slv">sistemsko zdravljenje</subject><subject language_type_id="slv">vismodegib</subject><title>Novosti v sistemskem zdravljenju bazalnoceličnega karcinoma</title></Record>